Bionovate Technologies Corp (BIIO)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2022 | - USD | 0.0% |
| 2021 | - USD | -100.0% |
| 2020 | 237.38 Thousand USD | 28.06% |
| 2019 | 185.37 Thousand USD | -17.5% |
| 2018 | 224.69 Thousand USD | -16.53% |
| 2017 | 269.17 Thousand USD | 41.37% |
| 2016 | 190.4 Thousand USD | 20442.31% |
| 2015 | -936.00 USD | -51.7% |
| 2014 | -617.00 USD | 36.19% |
| 2013 | -967.00 USD | 98.32% |
| 2012 | -57.67 Thousand USD | -9293.65% |
| 2011 | -614.00 USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 Q1 | - USD | 0.0% |
| 2022 Q2 | - USD | 0.0% |
| 2022 Q3 | - USD | 0.0% |
| 2022 Q4 | - USD | 0.0% |
| 2022 FY | - USD | 0.0% |
| 2022 Q1 | - USD | 0.0% |
| 2021 FY | - USD | -100.0% |
| 2021 Q1 | 237.52 Thousand USD | 0.06% |
| 2020 Q2 | 200.84 Thousand USD | 6.15% |
| 2020 FY | 237.38 Thousand USD | 28.06% |
| 2020 Q3 | 231.08 Thousand USD | 15.06% |
| 2020 Q1 | 189.21 Thousand USD | 2.07% |
| 2020 Q4 | 237.38 Thousand USD | 2.73% |
| 2019 Q2 | 244.15 Thousand USD | 8.42% |
| 2019 FY | 185.37 Thousand USD | -17.5% |
| 2019 Q4 | 185.37 Thousand USD | 1.09% |
| 2019 Q1 | 225.18 Thousand USD | 0.22% |
| 2019 Q3 | 183.37 Thousand USD | -24.89% |
| 2018 Q4 | 224.69 Thousand USD | 34.89% |
| 2018 FY | 224.69 Thousand USD | -16.53% |
| 2018 Q3 | 166.57 Thousand USD | 4.06% |
| 2018 Q2 | 160.07 Thousand USD | 11.97% |
| 2018 Q1 | 142.95 Thousand USD | -46.89% |
| 2017 Q2 | 46.07 Thousand USD | 1.4% |
| 2017 Q1 | 45.43 Thousand USD | -76.14% |
| 2017 FY | 269.17 Thousand USD | 41.37% |
| 2017 Q4 | 269.17 Thousand USD | 678.21% |
| 2017 Q3 | 34.58 Thousand USD | -24.93% |
| 2016 Q2 | -6478.00 USD | -313.4% |
| 2016 FY | 190.4 Thousand USD | 20442.31% |
| 2016 Q3 | 27.67 Thousand USD | 527.14% |
| 2016 Q1 | -1567.00 USD | -67.41% |
| 2016 Q4 | 190.4 Thousand USD | 588.12% |
| 2015 Q4 | -936.00 USD | -28.04% |
| 2015 Q2 | -669.00 USD | -60.82% |
| 2015 Q1 | -416.00 USD | 32.58% |
| 2015 Q3 | -731.00 USD | -9.27% |
| 2015 FY | -936.00 USD | -51.7% |
| 2014 Q2 | -2256.00 USD | -32.16% |
| 2014 Q1 | -1707.00 USD | -76.53% |
| 2014 FY | -617.00 USD | 36.19% |
| 2014 Q4 | -617.00 USD | 59.35% |
| 2014 Q3 | -1518.00 USD | 32.71% |
| 2013 FY | -967.00 USD | 98.32% |
| 2013 Q4 | -967.00 USD | 51.77% |
| 2013 Q2 | -7137.00 USD | 76.32% |
| 2013 Q3 | -2005.00 USD | 71.91% |
| 2013 Q1 | -30.13 Thousand USD | 47.75% |
| 2012 FY | -57.67 Thousand USD | -9293.65% |
| 2012 Q4 | -57.67 Thousand USD | 29.75% |
| 2012 Q3 | -82.1 Thousand USD | 26.13% |
| 2012 Q2 | -111.14 Thousand USD | 0.0% |
| 2012 Q1 | - USD | 100.0% |
| 2011 FY | -614.00 USD | 0.0% |
| 2011 Q4 | -614.00 USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| BioElectronics Corporation | 14.82 Million USD | 100.0% |
| Medical Supply International USA, Inc. | 216.6 Thousand USD | 100.0% |
| Polarean Imaging plc | -5.94 Million USD | 100.0% |
| Avitar, Inc. | 5.17 Million USD | 100.0% |
| CVR Medical Corp. | - USD | NaN% |
| IR-Med Inc. | -606 Thousand USD | 100.0% |
| AVITA Medical, Inc. | -26.23 Million USD | 100.0% |
| Manhattan Scientifics, Inc. | -7000.00 USD | 100.0% |
| Össur hf. | 395.08 Million USD | 100.0% |
| Zecotek Photonics Inc. | 2.76 Million USD | 100.0% |
| QHSLab, Inc. | 1.72 Million USD | 100.0% |
| Wellstar International, Inc. | 51.36 Million USD | 100.0% |
| Össur hf. | 395.08 Million USD | 100.0% |
| EKF Diagnostics Holdings plc | -4.61 Million USD | 100.0% |
| Escalon Medical Corp. | 315.68 Thousand USD | 100.0% |
| Aurora Spine Corporation | 1.9 Million USD | 100.0% |
| BrainsWay Ltd. | -10.32 Million USD | 100.0% |
| Lattice Biologics Ltd. | - USD | NaN% |
| NewCardio, Inc. | 2.41 Million USD | 100.0% |
| Hamilton Thorne Ltd. | 18.12 Million USD | 100.0% |
| Vivos Inc. | -1.59 Million USD | 100.0% |
| MicroPort Scientific Corporation | 673.58 Million USD | 100.0% |
| Kelyniam Global, Inc. | 487.33 Thousand USD | 100.0% |
| REMSleep Holdings, Inc. | -540.98 Thousand USD | 100.0% |
| CYduct Diagnostics, Inc. | 640.19 Thousand USD | 100.0% |
| Nanomix Corporation | 11.38 Million USD | 100.0% |
| Theraclion SA | -5.86 Million EUR | 100.0% |
| Lifeline Biotechnologies, Inc. | - USD | NaN% |
| Wellness Center USA, Inc. | 3.98 Million USD | 100.0% |
| Positron Corporation | 1.68 Million USD | 100.0% |
| Rafina Innovations Inc. | - USD | NaN% |
| Electromedical Technologies, Inc. | 1.61 Million USD | 100.0% |
| Lombard Medical, Inc. | 11.49 Million USD | 100.0% |
| ALR Technologies Inc. | 19.14 Million USD | 100.0% |
| Stratec SE | 119.12 Million USD | 100.0% |
| Vycor Medical, Inc. | 1.05 Million USD | 100.0% |
| Heart Tronics, Inc. | 54.99 Thousand USD | 100.0% |
| Nu-Med Plus, Inc. | 93.19 Thousand USD | 100.0% |
| Perimeter Medical Imaging AI, Inc. | -13.78 Million USD | 100.0% |
| SANUWAVE Health, Inc. | 30.14 Million USD | 100.0% |
| VMS Rehab Systems, Inc. | 133.52 USD | 100.0% |
| Guided Therapeutics, Inc. | 1.46 Million USD | 100.0% |
| Ingen Technologies, Inc. | 630.91 Thousand USD | 100.0% |
| Odyssey Group International, Inc. | 2.1 Million USD | 100.0% |
| United American Healthcare Corporation | -9.32 Million USD | 100.0% |
| ECGI Holdings, Inc. | 3.17 Million USD | 100.0% |
| Capital Group Holdings, Inc. | -3508.00 USD | 100.0% |
| ADM Tronics Unlimited, Inc. | 262.61 Thousand USD | 100.0% |
| Urologix, Inc. | 4.61 Million USD | 100.0% |
| Rapid Therapeutic Science Laboratories, Inc. | 4.2 Million USD | 100.0% |
| Nexeon MedSystems Inc. | 3.33 Million USD | 100.0% |
| SS Innovations International, Inc. | 1.18 Million USD | 100.0% |
| Qualis Innovations, Inc. | 6671.00 USD | 100.0% |
| Smith & Nephew plc | 2.77 Billion USD | 100.0% |
| NIOX Group Plc | -23.93 Million USD | 100.0% |
| Fuse Medical, Inc. | 1.75 Million USD | 100.0% |
| Broncus Holding Corporation | -81.42 Million USD | 100.0% |
| Brain Scientific Inc. | 2.11 Million USD | 100.0% |
| Pressure BioSciences, Inc. | 22.67 Million USD | 100.0% |
| Health Logic Interactive Inc. | 39.55 Thousand USD | 100.0% |